Healthy Adult Subjects
61
2
2
54
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
54 completed trials (89% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 61 trials
98.2%
+11.7% vs benchmark
2%
1 trials in Phase 3/4
17%
9 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 54 completed trials
Clinical Trials (61)
Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects
A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.
Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
Study of Oral Edaravone in Healthy Adult Males
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube
Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
An Open-label DDI Study of Omaveloxolone in Healthy Subjects
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone
A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants
Dietary Supplement With and Without a Probiotic
A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
Safety, Tolerability and Pharmacokinetics Study of CK-3773274
A Study of TTYP01 in Healthy Adult Subjects
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects
A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China
Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects